Skip to main content

Table 2 Demographic and Clinical Characteristics of Included Patients

From: Automated deep-learning system in the assessment of MRI-visible prostate cancer: comparison of advanced zoomed diffusion-weighted imaging and conventional technique

Variable

Patients without cancer (n = 180)

Patients with cancer (n = 174)

Median age (year)a

69 (65 - 75)

72 (66 - 79)

Total PSA (ng/ml)a

8.9 (5.1 - 13.0)

14.0 (6.7 - 29.6)

Free PSA (ng/ml)a

1.3 (0.8 - 2.3)

1.6 (0.8 - 3.5)

Free PSA/total PSAa

0.2 (0.1 - 0.2)

0.1 (0.1 - 0.2)

No. of patients with MRI-detected lesionsb

 1 lesion

145 (81)

107 (61)

 2 lesions

21 (12)

59 (34)

 3 lesions

8 (4)

7 (4)

 More than 3 lesions

6 (3)

1 (1)

  1. PSA prostate-specific antigen, PI-RADS Prostate Imaging Reporting and Data System
  2. aData in parentheses are the interquartile range
  3. bData in parentheses are percentages